Cytokinetics, Incorporated
USD82.19
+1.39 (+1.72%)
CEO
Robert I. Blum
IPO Date
2004-04-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$80.80
Prev. Close
$80.80
Day Low
$80.04
Day High
$84.55
52W Low
$32.66
52W High
$84.55
Market Cap
$10.23B
Volume
7.16M
| 3,500 |
| $79.51 |
| 23 Jun 2026 | Malik Fady Ibraham | EVP Research & Development | M-Exempt | Disposed | 3,500 | $7.80 |
| 15 Jun 2026 | Blum Robert I | director, officer: President & CEO | S-Sale | Disposed | 7,500 | $70.46 |
| 9 Jun 2026 | Malik Fady Ibraham | EVP Research & Development | M-Exempt | Acquired | 3,500 | $7.80 |
| 9 Jun 2026 | Malik Fady Ibraham | EVP Research & Development | S-Sale | Disposed | 3,500 | $67.98 |
| 9 Jun 2026 | Malik Fady Ibraham | EVP Research & Development | M-Exempt | Disposed | 3,500 | $7.80 |
| 1 Jun 2026 | Kaye Edward M. MD | director | S-Sale | Disposed | 2,933 | $76.09 |
| 1 Jun 2026 | Callos Andrew | EVP, Chief Commercial Officer | M-Exempt | Acquired | 15,000 | $23.26 |
| 1 Jun 2026 | Callos Andrew | EVP, Chief Commercial Officer | S-Sale | Disposed | 15,000 | $74.08 |